Harry Alexopoulos
Overview
Explore the profile of Harry Alexopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1057
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsiortou P, Alexopoulos H, Kyriakidis K, Kosmidis M, Barba C, Akrivou S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Feb;
12(2):e200373.
PMID: 39933127
Background And Objectives: The aim of this study was to identify genetic markers and immunologic characteristics of glutamic acid decarboxylase (GAD) antibody-positive patients with stiff-person syndrome (SPS). Methods: We conducted...
2.
Stavropoulou De Lorenzo S, Andravizou A, Alexopoulos H, Michailidou I, Bokas A, Kesidou E, et al.
Biomedicines
. 2024 Jun;
12(6).
PMID: 38927526
The use of immune checkpoint inhibitors (ICIs) for the treatment of various advanced and aggressive types of malignancy has significantly increased both survival and long-term remission rates. ICIs block crucial...
3.
Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis-A Systematic Review
Alentorn A, Berzero G, Alexopoulos H, Tzartos J, Reyes Botero G, Morales Martinez A, et al.
Biomedicines
. 2023 Jun;
11(6).
PMID: 37371620
Anti-NMDAR encephalitis has been associated with multiple antigenic triggers (i.e., ovarian teratomas, prodromal viral infections) but whether geographic, climatic, and environmental factors might influence disease risk has not been explored...
4.
Alexopoulos H, Trougakos I, Dimopoulos M, Terpos E
Eur J Intern Med
. 2022 Dec;
108:104-105.
PMID: 36586739
No abstract available.
5.
Alexopoulos H, Trougakos I, Dimopoulos M, Terpos E
Eur J Intern Med
. 2022 Nov;
107:7-16.
PMID: 36379820
In the COVID-19 pandemic era, antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has proven an invaluable tool and herein we highlight some of the most useful clinical...
6.
Trougakos I, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, et al.
Trends Mol Med
. 2022 Sep;
28(10):800-802.
PMID: 36114090
No abstract available.
7.
Ntanasis-Stathopoulos I, Karalis V, Gavriatopoulou M, Malandrakis P, Sklirou A, Eleutherakis-Papaiakovou E, et al.
Hemasphere
. 2022 Aug;
6(8):e764.
PMID: 35928542
COVID-19 vaccination leads to a less intense humoral response in patients with multiple myeloma (MM) compared with healthy individuals, whereas the SARS-CoV-2-specific immunity fades over time. The purpose of this...
8.
Ntanasis-Stathopoulos I, Karalis V, Sklirou A, Gavriatopoulou M, Alexopoulos H, Malandrakis P, et al.
Hemasphere
. 2022 Jul;
6(7):e747.
PMID: 35813098
No abstract available.
9.
Trougakos I, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, et al.
Trends Mol Med
. 2022 May;
28(7):542-554.
PMID: 35537987
Vaccination is a major tool for mitigating the coronavirus disease 2019 (COVID-19) pandemic, and mRNA vaccines are central to the ongoing vaccination campaign that is undoubtedly saving thousands of lives....
10.
Marignier R, Hacohen Y, Cobo-Calvo A, Probstel A, Aktas O, Alexopoulos H, et al.
Lancet Neurol
. 2021 Aug;
20(9):762-772.
PMID: 34418402
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently identified autoimmune disorder that presents in both adults and children as CNS demyelination. Although there are clinical phenotypic overlaps between MOGAD, multiple...